14.01
前日終値:
$13.73
開ける:
$13.86
24時間の取引高:
368.36K
Relative Volume:
0.64
時価総額:
$651.57M
収益:
$701.20M
当期純損益:
$-72.90M
株価収益率:
-8.8896
EPS:
-1.576
ネットキャッシュフロー:
$43.10M
1週間 パフォーマンス:
+2.64%
1か月 パフォーマンス:
-0.64%
6か月 パフォーマンス:
+21.19%
1年 パフォーマンス:
-2.23%
Avanos Medical Inc Stock (AVNS) Company Profile
名前
Avanos Medical Inc
セクター
電話
844-428-2667
住所
5405 WINDWARD PARKWAY, ALPHARETTA, GA
Compare AVNS vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
AVNS
Avanos Medical Inc
|
14.01 | 638.55M | 701.20M | -72.90M | 43.10M | -1.576 |
|
ABT
Abbott Laboratories
|
102.67 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
328.59 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.65 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
62.75 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
80.08 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
Avanos Medical Inc Stock (AVNS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-07-25 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-22 | 開始されました | CL King | Buy |
| 2021-08-04 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2020-04-13 | アップグレード | Barclays | Underweight → Equal Weight |
| 2019-11-07 | ダウングレード | Stifel | Buy → Hold |
| 2019-11-06 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2018-10-16 | 開始されました | Barclays | Equal Weight |
| 2018-08-21 | アップグレード | Raymond James | Mkt Perform → Outperform |
すべてを表示
Avanos Medical Inc (AVNS) 最新ニュース
Options Flow: Is Avanos Medical Inc a good ESG investment2026 Price Targets & Daily Entry Point Alerts - baoquankhu1.vn
AVNS PE Ratio & Valuation, Is AVNS Overvalued - intellectia.ai
Avanos Medical (NYSE:AVNS) Rating Increased to Buy at Wall Street Zen - MarketBeat
Rate Hike: Can Avanos Medical Inc grow without external funding2026 Big Picture & Community Supported Trade Ideas - baoquankhu1.vn
Vanguard disaggregates holdings; Avanos (AVNS) shows 0 shares after realignment - Stock Titan
Reasons to retain Avanos Medical stock in your portfolio for now - MSN
Aug Final Week: What is the dividend yield of Avanos Medical IncSwing Trade & Real-Time Stock Entry Alerts - baoquankhu1.vn
Zacks Research Cuts Earnings Estimates for Avanos Medical - MarketBeat
AVANOS MEDICAL unveils RxCrush device aimed at simplifying medication delivery for nurses - Traders Union
AVNS Financials: Revenue Breakdown, Margins & Competitor Comparison - intellectia.ai
Analysts Set Expectations for Avanos Medical FY2026 Earnings - MarketBeat
Reasons to Retain Avanos Medical Stock in Your Portfolio for Now - zacks.com
Reasons to Keep Avanos Medical Shares in Your Investment Portfolio at This Time - Bitget
Avanos Medical tops Q4 earnings and revenue forecasts - MSN
Avanos Medical (AVNS) CFO receives new stock options and RSUs - Stock Titan
Avanos Medical (NYSE: AVNS) CEO receives new stock options and RSUs - Stock Titan
Avanos Medical (AVNS) grants SVP Delgado stock options and RSUs - Stock Titan
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Avanos Medical, Inc. (NYSE: AVNS) - PR Newswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Discipline and Rules-Based Execution in AVNS Response - Stock Traders Daily
EV Market: Does Avanos Medical Inc meet Warren Buffetts criteria2026 Major Catalysts & Low Risk High Win Rate Stock Picks - baoquankhu1.vn
Avanos Medical Inc Stock Faces Analyst Downgrade as FY2026 Guidance Signals Caution - AD HOC NEWS
Cove Street Capital LLC Grows Stock Holdings in Avanos Medical, Inc. $AVNS - MarketBeat
Avanos Medical (NYSE:AVNS) Downgraded by Wall Street Zen to Hold - MarketBeat
AVANOS MEDICAL, INC. ($AVNS) CEO 2025 Pay Revealed - Quiver Quantitative
Avanos Medical, Inc. Files Form 8-K with SEC Detailing Corporate Information and Common Stock Listing on NYSE - Minichart
Avanos Medical increases CEO long-term incentive target to $5.5 million - Investing.com
Avanos Medical increases CEO long-term incentive target to $5.5 million By Investing.com - Investing.com South Africa
Avanos Medical boosts CEO long-term incentive compensation - TipRanks
Avanos Medical (NYSE: AVNS) raises CEO long-term incentive grant target - Stock Titan
FOMO Trade: Can Avanos Medical Inc grow without external funding2026 Outlook & AI Forecasted Stock Moves - baoquankhu1.vn
Avanos Medical at Citizens Life Sciences: Strategic Growth and Challenges By Investing.com - Investing.com Canada
Avanos (NYSE: AVNS) officer surrenders 226 shares to cover RSU tax - Stock Titan
AVANOS (NYSE: AVNS) CFO surrenders shares to cover RSU tax withholding - Stock Titan
Elastomeric Infusion Pumps Market size to cross $1.95 Billion - openPR.com
[Form 4] AVANOS MEDICAL, INC. Insider Trading Activity - Stock Titan
Death Cross: Is Avanos Medical Inc a good ESG investment2026 Snapshot & Daily Volume Surge Signals - baoquankhu1.vn
Avanos Medical launches new resource page for NICU and PICU pharmacists - Traders Union
Behavioral Patterns of AVNS and Institutional Flows - Stock Traders Daily
Avanos Medical, Inc. (NYSE:AVNS) Short Interest Update - MarketBeat
Avanos Medical, Inc. to Present at the 2026 Citizens Life Sciences Conference - PR Newswire
Avanos Medical to nominate James Cunniff, William Burke to board - Medical Buyer
Avanos Medical (NYSE:AVNS) Downgraded by Wall Street Zen to Buy - MarketBeat
Avanos Medical, Inc. (AVNS) Stock Analysis: Navigating Challenges in the Medical Device Sector - DirectorsTalk Interviews
Avanos Medical nominates two directors to board - Investing.com
Avanos Medical to nominate James Cunniff and William Burke to board of directors - marketscreener.com
Avanos Medical To Nominate James Cunniff And William Burke To Board - citybiz
Avanos Medical nominates two directors to board By Investing.com - Investing.com Canada
Avanos Medical Reaches Cooperation Deal, Refreshes Board Governance - TipRanks
Avanos Medical To Nominate James Cunniff And William Burke To Board Of Directors - TradingView
Avanos Medical (NYSE: AVNS) adds Cunniff, Burke nominees in Radoff pact - Stock Titan
Avanos Medical Inc (AVNS) 財務データ
収益
当期純利益
現金流量
EPS
Avanos Medical Inc (AVNS) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Galovan Scott Michael | SVP, Chief Financial Officer |
Mar 06 '26 |
Option Exercise |
13.79 |
5,907 |
81,458 |
116,916 |
| Holbrook Kerr | SVP, Chief Commercial Officer |
Nov 18 '25 |
Sale |
11.00 |
15,000 |
165,014 |
83,860 |
大文字化:
|
ボリューム (24 時間):